A pioneering TechBio company founded in Cairo in 2020, now operating across Egypt, the US, and the MENA region. The company transforms drug discovery by integrating advanced AI with biotechnology to engineer next-generation biotherapeutics. Proteinea developed Ankh—the world’s top-performing protein language model, backed by Google—functioning like ChatGPT but for proteins. This breakthrough enables smarter, faster, and safer design of antibody therapeutics for treating diseases from arthritis to cancer. Admitted into Silicon Valley’s prestigious IndieBio accelerator and backed by leading investors. Proteinea is revolutionizing how life-saving medicines are created.